NASDAQ: URGNUrogen Pharma Ltd Stock Ownership - Who owns Urogen Pharma?
Insider buying vs selling
Have Urogen Pharma Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark Schoenberg | Chief Medical Officer | 2025-11-19 | 10,000 | $25.00 | $250.00kSell |
| Chris Degnan | Chief Financial Officer | 2025-10-08 | 2,203 | $16.85 | $37.12kSell |
| Jason Drew Smith | General Counsel | 2025-09-08 | 1,520 | $19.11 | $29.05kSell |
| Mark Schoenberg | Chief Medical Officer | 2025-09-08 | 871 | $19.11 | $16.64kSell |
| Mark Schoenberg | Chief Medical Officer | 2025-08-11 | 10,000 | $17.69 | $176.90kSell |
| Mark Schoenberg | Chief Medical Officer | 2025-07-28 | 5,149 | $19.14 | $98.55kSell |
| Jason Drew Smith | General Counsel | 2025-07-28 | 7,522 | $19.14 | $143.97kSell |
| Mark Schoenberg | Chief Medical Officer | 2025-06-09 | 5,162 | $7.37 | $38.04kSell |
| Jason Drew Smith | General Counsel | 2025-01-31 | 3,354 | $11.14 | $37.36kSell |
| Jason Drew Smith | General Counsel | 2025-01-31 | 2,767 | $11.14 | $30.82kSell |
URGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when URGN insiders and whales buy or sell their stock.
URGN Shareholders
What type of owners hold Urogen Pharma Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ran Nussbaum | 16.39% | 7,674,072 | $176.35M | Insider |
| Rtw Investments LP | 9.71% | 4,543,895 | $104.42M | Institution |
| Paradigm Biocapital Advisors LP | 9.01% | 4,216,084 | $96.89M | Institution |
| Toronto Dominion Bank | 6.82% | 3,190,510 | $73.32M | Institution |
| Blackrock Inc | 5.51% | 2,581,286 | $59.32M | Institution |
| Morgan Stanley | 5.40% | 2,528,446 | $58.10M | Institution |
| Jefferies Financial Group Inc | 4.70% | 2,199,652 | $50.55M | Institution |
| Silverarc Capital Management LLC | 3.37% | 1,577,283 | $36.25M | Institution |
| Millennium Management LLC | 3.14% | 1,468,737 | $33.75M | Institution |
| Acorn Capital Advisors LLC | 2.69% | 1,259,749 | $28.95M | Institution |
URGN vs Biotech Stocks
Urogen Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.